This study aimed to evaluate the effectiveness of use of Continuous Glucose Monitoring (CGM), combined with personalized dietary education and use of smartphone applications in improving glucose control and weight management.
Subjects over the age of 19
Patients with type 2 diabetes
Fasting blood glucose ≥ 126 mg/dL or
HbA1c ≥ 6.5% or
Subjects less than 19 years old
Patients with type 1 diabetes
Pregnant at the time of screening or planning to become pregnant during the study
Severe chronic diseases such as cancer, stroke, proliferative retinopathy, myocardial infarction, chronic renal disease, or amputation of a diabetic foot
Single group
Freestyle Libre
DeviceGlycemic control was monitored using CGM data for two weeks, followed by individualized dietary education.
HbA1c
HbA1c assessed by blood test after 2-week use of CGM and dietary education
Fasting blood glucose
Fasting blood glucose, assessed by blood test after 2-week use of CGM and dietary education
Lipid profiles
Lipid profiles (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride), assessed by blood test after 2-week use of CGM and dietary education
Body weight
Body weight assessed by blood test after 2-week use of CGM and dietary education
Pre- and post-intervention questionnaire: Diabetes Treatment Satisfaction Questionnaire (DTSQ)
Pre- and post-intervention questionnaires, assessed by self-reported survey. The questionnaire is composed of three parts. * total satisfaction (minimum 0, maximum 36, higher scores mean a better outcome.) * perceived hyperglycaemia (minimum 0, maximum 6, higher scores mean a worse outcome.) * perceived hypoglycaemia (minimum 0, maximum 6, higher scores mean a worse outcome.)
Click on the lead sponsor to view all of their trials.
Kangbuk Samsung Hospital
Lead sponsor
Samsung Electronics
Collaborator
